ESSA Pharma Inc.

The momentum for this stock is not very good. ESSA Pharma Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in ESSA Pharma Inc..
Log in to see more information.
ESSA Pharma, Inc. engages in the development of small molecule drugs for prostate cancer. It focuses...

News

ESSA Pharma Breaks Above 200-Day Moving Average - Bullish for EPIX
ESSA Pharma Breaks Above 200-Day Moving Average - Bullish for EPIX

Market News Video In trading on Wednesday, shares of ESSA Pharma Inc (EPIX) crossed above their 200 day moving average of 6.74, changing hands as high as 7.06 per share. ESSA Pharma Inc shares are currently...\n more…

ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference
ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference

PR Newswire ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference PR Newswire SOUTH SAN FRANCISCO, Calif. and VANCOUVER...\n more…

Piper Sandler Keeps Their Buy Rating on ESSA Pharma (EPIX)
Piper Sandler Keeps Their Buy Rating on ESSA Pharma (EPIX)

TipRanks Financial Blog Piper Sandler analyst Joseph Catanzaro maintained a Buy rating on ESSA Pharma (EPIX - Research Report) today and set a price target of $15.00. The ...\n more…

Companies Like ESSA Pharma (NASDAQ:EPIX) Are In A Position To Invest In Growth
Companies Like ESSA Pharma (NASDAQ:EPIX) Are In A Position To Invest In Growth

Simply Wall St We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...\n more…

ESSA Pharma (NASDAQ:EPIX) Share Price Passes Below 50 Day Moving Average of $5.09
ESSA Pharma (NASDAQ:EPIX) Share Price Passes Below 50 Day Moving Average of $5.09

Ticker Report ESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $5.09 and traded as low as...\n more…

ESSA Pharma (EPIX) Receives a Buy from Oppenheimer
ESSA Pharma (EPIX) Receives a Buy from Oppenheimer

TipRanks Financial Blog In a report released today, Leland Gershell from Oppenheimer maintained a Buy rating on ESSA Pharma (EPIX - Research Report), with a price target o...\n more…